Literature DB >> 31166017

Carotid Cavernous Fistula Mimicking Hemicrania Continua: A Case Report.

Catherine Arnold Fiebelkorn1, Giuseppe Lanzino2, John J Chen3, Waleed Brinjikji4, Laurence J Eckel4, Christopher J Boes1.   

Abstract

BACKGROUND: Hemicrania continua is a primary headache disorder characterized by a continuous, unilateral headache associated with ipsilateral cranial autonomic features that responds to indomethacin. By definition, the symptoms are not referable to an underlying structural pathology. However, several cases of secondary hemicrania continua related to underlying structural lesions have been reported. CASE: We present a case of a 53-year-old male with a prolonged, right-sided headache associated with intermittent right-sided ptosis, conjunctival injection, tearing, and nasal congestion, suggestive of hemicrania continua, who was found to have an indirect carotid-cavernous fistula, and who, after endovascular treatment of the fistula, had resolution of his symptoms.
CONCLUSION: Alternative, and perhaps less common, causes of headache should be considered when the clinical presentation is atypical or does not clearly fulfill diagnostic criteria for primary headache disorders. Carotid cavernous fistulas should be included within this differential, and represent a potentially treatable and reversible cause of otherwise refractory headache.
© 2019 American Headache Society.

Entities:  

Keywords:  carotid cavernous fistula; headache; hemicrania continua

Year:  2019        PMID: 31166017     DOI: 10.1111/head.13566

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  2 in total

1.  Hemicrania continua associated with an unruptured anterior communicating artery aneurysm: first case report.

Authors:  Ibrahim Imam
Journal:  J Headache Pain       Date:  2021-03-08       Impact factor: 7.277

2.  Hemicranial postural headache as a first symptom of a spontaneous carotid cavernous fistula: A case report.

Authors:  Li Liu; Yushi Zhong; Bin Wu; Xianbi Tang; Ziwei Yi; Chuzheng Pan
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.